Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year over year increase in its fiscal fourth quarter revenues and a 6 percent increase in fiscal year 2018 revenues.

For the quarter ended Sept. 30, the diagnostics manufacturer reported revenues of $53.1 million compared to $49.7 million in the prior year, beating analysts' consensus estimate of $51.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.